Chemical and petrochemical

N/A | May 19, 2017

article image
You will find a large selection of pressure and temperature and level measuring instruments to suit your specific requirements.Individually tailored advice and proposals, to match solutions to your needs, supplement our extensive offering of products and services. Our expertise and dependability,
in addition to our worldwide sales and service network, has made WIKA a global contracting partner with many wellknown names in the international chemical and petrochemical industries.

Spotlight

BioMarin Pharmaceutical Inc.

BioMarin is a global pharmaceutical company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. We remain steadfast to our original mission to bring new treatments to market that will make a big impact on small patient populations. These patient populations are mostly children, suffering from diseases so rare, that the entire patient population can number as few as 1,000 people worldwide. These conditions are often inherited, difficult to diagnose, progressively debilitating, have few, if any, treatment options and are usually ignored.

OTHER ARTICLES

Improving 3D Chemical Visualization of Subsurface Structures

Article | February 19, 2020

A Raman microscope combines a Raman spectrograph and a light microscope to gain chemical and structural information from materials down to the micron scale. Raman spectroscopy observes when the wavelength of light changes as it interacts with a molecule. The different wavelengths seen in Raman scattering can identify and study vibrational, rotational, and bending forces within chemical bonds of a molecule.

Read More

Sustainability: A Core Initiative for Collaboration in the Chemical Industry

Article | February 19, 2020

Legislation and pressure from stakeholders are forcing the chemical industry to find efficiencies and urgently seek out ways to reduce environmental impact, such as implementing low-carbon initiatives, maximizing energy and water efficiency and developing new innovative products and processes. Last month’s World Economic Forum added further urgency as shareholders and investment groups added new sustainability criteria to their investment considerations. As the pressure to improve sustainability rises, organizations like SusChem, the European Technology Platform for Sustainable Chemistry, are gaining visibility and traction.

Read More

Why chemical characterization is the best way to assess patient risk

Article | February 11, 2020

Everyone is very familiar with the phrase when buying a house: All that really matters are three things - location, location, and location. This same principle applies to extractables and leachables chemistry analysis – the three things that truly matter are identification, identification, and identification. The greatest growth in the past ten years in demonstrating the safety of medical devices and container closure systems for drugs has been using analytical chemistry to determine what chemicals can leach from the device and what the patient is exposed to during its intended use.

Read More

Why QuickStart Chemical Management Can Save Your Assets

Article | February 27, 2020

The world of Environmental, Health and Safety (EHS) IT systems is a vast one. Therefore, it cannot be stressed enough that organizations need to be nimble and armed with easy-to-deploy, interoperable, portable systems. Most mature organizations opt for a risk-based EHS management system framework designed to meet a continually evolving and dynamic business and operating model. A risk-based approach offers flexibility, within defined boundaries, for alternate solutions to risk management needs. Standard frameworks recommend mandatory controls when there is potential for high-consequence events. Moreover, risk control measures which have been proven effective and considered technically superior are increasingly used.

Read More

Spotlight

BioMarin Pharmaceutical Inc.

BioMarin is a global pharmaceutical company focused on developing first-in-class and best-in-class therapeutics that provide meaningful advances to patients who live with serious and life-threatening rare genetic diseases. We remain steadfast to our original mission to bring new treatments to market that will make a big impact on small patient populations. These patient populations are mostly children, suffering from diseases so rare, that the entire patient population can number as few as 1,000 people worldwide. These conditions are often inherited, difficult to diagnose, progressively debilitating, have few, if any, treatment options and are usually ignored.

Events